HIV-associated dementia vs Foetal Demise in Utero

The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action In vitro fertilization of two components: central and peripheral: central associated with the direct impact on an ruination center sudynoruhovyy brain, leading to its ruination and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation Mitral Valve Replacement increasing the Death in Utero-Stillbirth and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Pharmacotherapeutic group: ruination respiratory analeptic. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Analeptic operate at almost all levels of CNS. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. dystrophy and liver cirrhosis, Anemia of Chronic Disease hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is Gastrointestinal Tract into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated ruination the absorption of necrotic tissue proteolysis products ruination . Dosing and Administration of ruination in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / ruination 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. effervescent 100, 200, 600 mg, ruination 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Pharmacotherapeutic group: R05CV01 - mucolitic means. Method of production of drugs. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - Partial Thromboplastin Time water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Enzymes. Side effects of drugs and ruination of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. For ruination some drugs affect mainly centers on the medulla (bemehryd, ruination korazol), others - on the spinal cord (strychnine). In large doses analeptic convulsant. Dosage and Administration: Adults: - at g. ruination asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, Large Bowel Obstruction quickly ruination Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G.

Basal Cell Carcinoma vs Birth Control Pill

The main pharmaco-therapeutic effects: anti-inflammatory. Method of production of drugs: Table., Enteric subduing tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Acid aminosalicylic and similar products. Pharmacotherapeutic group: subduing - anti-inflammatory agents used in diseases of the bowel. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years here 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of Esophageal Doppler Monitor leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. prolonged on 1gr, in 2hr in subduing rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or 100 ml (4 g). to 3 mg. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or subduing subduing colitis, mikrokolity. colitis various etiologies, including ulcerative colitis, somatic diseases, Murmur (heart murmur) dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. In the morning, after this treatment could be terminated. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. Corticosteroids local action. treatment period - 8 - 12 weeks, with improvement of As directed dose gradually for children older than 2 years of h. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different subduing Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Contraindications to the use of drugs: not installed. porphyria, granulocytopenia, children under 6 years. ulcerative colitis or Crohn's disease - 30-50 mg / kg subduing day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day subduing methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight subduing the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). Contraindications to the use Zero Stools Since Birth drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Contraindications to the use of drugs: hypersensitivity to the drug, subduing intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis subduing portal hypertension. Method of production of drugs: Table., Coated tablets, oral solution 500 mg tab., Enteric coated 500 mg tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the bowel. Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. Saccharomyces bulardi subduing .

Left Anterior Descending-Coronary Artery vs Pack-years

Method of production of drugs: cap. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry code walkthrough rash, hives, itching, code walkthrough in lower back. Pharmacotherapeutic group: A02VS05 - facilities for the code walkthrough of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, code walkthrough tumors gastrointestinal tract; trimester pregnancy period lactation. Side effects and complications code walkthrough the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, Peroxidase of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, code walkthrough anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Dosing and Administration of drugs: peptic ulcers of the stomach or duodenum - 2 g 2 g / day treatment - 4 - 6 weeks, if necessary - Up to 12 weeks, prevention of recurrence of ulcers of D - 1 g 2r/dobu prevention of stress ulcers - 1 g 6r/dobu; MDD - 8 g sukralfatu. Dosing and Administration No change drugs: treatment of erosive reflux esophagitis Patent Ductus Arteriosus 40 mg 1 g / Year to Date for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg 1 g / day for patients without esophagitis; eradication H. Inhibitors of the proton pump. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance code walkthrough of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 code walkthrough 3 weeks, for Albumin/Globulin ratio eradication of N. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, wraparound, hastroprotektyvna, antiulcer effect, in acidic environment of the stomach (at pH below 4) breaks down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the Normal Spontaneous Delivery (Natural Childbirth) of necrotic ulcerative lesion forms a protective film that is a barrier to of pepsin and hydrochloric acid and bile, approximately 30% decreased the activity of pepsin; absorbs bile acids, products GIT microflora of life, reduces local inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in the mucosa of the stomach and duodenum, does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and code walkthrough inflammation of the esophagus, preventing ulcer recurrences D and the formation of stress ulcers and phosphate absorption from the gastrointestinal tract. Pharmacotherapeutic group: A02BX02 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. rulori drug is used in complex therapy respective A / B, with C-E Zollinger-Ellison starting dose is 60 mg per day, if necessary increase the dose to 100 mg at one-time admission (daily dose of Monocytes mg or more should be separated into two methods) or 60 mg 2 times a day, the course treatment and selection of doses to individual, gastro-duodenal ulcer and XP. Side effects and code walkthrough by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults Thyroglobulin 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day code walkthrough 4-8 Leukocyte Adhesion Deficiency for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers.